Example: tourism industry

A SUSTAINABLE FUTURE STARTS WITH HEALTH

A S U S TA I N A B L E F U T U R E. S TA R T S W I T H H E A LT H. THE ABBOT T 2030 SUSTAINABILIT Y PL AN. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. A S U S TA I N A B L E. F U T U R E S TA R T S. W I T H H E A LT H. A SUSTAINABLE FUTURE STARTS with HEALTH . It's the foundation for all we can do in life as individuals, families and communities. It helps societies thrive and fuels successful economies. At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve shaping the FUTURE of healthcare and helping the greatest number of people live better and healthier. 2. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N.

FUTURE STARTS WITH HEALTH A sustainable future starts with health. It’s the foundation for all we can do in life – as individuals, families and communities. It helps societies thrive and fuels successful economies. At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve – shaping the future

Tags:

  Future, Sustainability, The future

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of A SUSTAINABLE FUTURE STARTS WITH HEALTH

1 A S U S TA I N A B L E F U T U R E. S TA R T S W I T H H E A LT H. THE ABBOT T 2030 SUSTAINABILIT Y PL AN. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. A S U S TA I N A B L E. F U T U R E S TA R T S. W I T H H E A LT H. A SUSTAINABLE FUTURE STARTS with HEALTH . It's the foundation for all we can do in life as individuals, families and communities. It helps societies thrive and fuels successful economies. At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve shaping the FUTURE of healthcare and helping the greatest number of people live better and healthier. 2. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N.

2 OUR CHALLENGE. Looking ahead, the world faces immense HEALTH threats and major issues in confronting them. 18-YR. difference in life 1 in 3. people lack access $16T. in global healthcare DEBT. and immense budget expectancy between rich to essential spending needed by 2029, deficits limit funding and poor countries healthcare products nearly double from 2019 for HEALTH >70% ~20M 1 in 3 COVID-19. of all deaths can be attributed additional HEALTH workers people suffer from and other infectious diseases to chronic diseases needed by 2030 malnutrition affecting every community 3. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. OUR ROLE. The world needs new approaches to HEALTH . We all have a role to play. For healthcare innovators, business as usual won't get it done, and focusing on cutting-edge innovations alone won't be enough.

3 The best healthcare solution is the one that can reach the most people who need it. Society should judge the healthcare industry on our ability to create products that are not just effective but are affordable and accessible to more people. 4. I N T R O D U C T IO N / I NNOVAT I ON / F O UNDATIO N / C REATIO N & MAN AG EMEN T T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. OUR CLEAR. FOCUS. OUR PRIORITY. To impact the most lives, we must get our innovative healthcare I N N O VAT E F O R A C C E S S. solutions to people who need them. AND AFFORDABILIT Y. Our 2030 sustainability Plan is focused on designing access and Make access and Transform care Advance HEALTH affordability into our life-changing affordability core for chronic disease, equity through technologies and products, to new product malnutrition and partnership.

4 Working across our business and innovation. infectious diseases. in partnership with others to break down barriers and bring our HEALTH innovations to an increasing number of people. S U S TA I N A B I L I T Y I N E V E R Y T H I N G W E D O. Our work will touch the lives of 2 billion people this year, and we Build the diverse, Responsibly Create a resilient, Protect a healthy intend to reach over 1 billion innovative connect data, diverse and environment. more in the next 10 years workforce technology responsible . of tomorrow. and care. supply chain. improving the lives of 1 in every 3. people on the planet by 2030. 5. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. PA R T 1. I N N O VAT I O N. F O R A H E A LT H I E R , MORE RESILIENT WORLD. Janhvi Dubey, one of our college interns, says an Abbott mentor helped her decide to major in biomedical engineering.

5 Her belief: Lead through service. Her hope: Find ways to help others through technology and robotics. 6. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. OUR PRIORITY. I N N O VAT E F O R A C C E S S. AND AFFORDABILIT Y. We're intentionally designing INNOVATE TR ANS F OR M PAR TNER. access and affordability into many ake access and affordability M Transform care for chronic dvance HEALTH equity A. of our life-changing technologies core to new product disease, malnutrition and through partnership. and products, and breaking down innovation. infectious diseases. barriers that prevent people from getting the care they need. We'll design our technologies Across our business and We will work side-by-side with and products for broader access through collaboration, we'll people and communities we and affordability at every step create new technologies and serve, partners, governments from every phase of our R&D find new answers for chronic and other stakeholders to process, to the materials we use, HEALTH conditions like diabetes address HEALTH disparities, to manufacturing, to the ways we and cardiovascular disease, expand access and remove reach the people who need them.

6 Malnutrition, and infectious barriers that prevent people diseases such as COVID-19, from living healthy lives, HIV, malaria and hepatitis, wherever they are. as well as tomorrow's pandemic threats. 7. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. TA K I N G A C T I O N. W I T H TA R G E T E D G O A L S. Make access and affordability core to new Transform care for chronic disease, Advance HEALTH equity through product innovation malnutrition and infectious diseases partnership Integrate access, affordability and data insights as Support global efforts to address noncommunicable Expand affordable access to healthcare for design principles into our R&D work and portfolio. diseases, including diabetes and cardiovascular disease. underserved, diverse and at-risk communities, including women and children, by delivering - Innovate to transform the standard of care for innovative, decentralized models of care that diabetes and support efforts to bend the diabetes advance prevention and early diagnosis, improve curve through innovative technology, prevention and nutrition, provide quality treatment and care, education, early diagnosis, treatment and nutrition.

7 And lower total costs. - Deliver breakthrough technologies, improve clinical Partner with stakeholders to improve HEALTH outcomes and impact the lives of people with or at outcomes by advancing standards and building risk of cardiovascular disease. access to affordable, integrated solutions. Deliver scalable, integrated solutions to help reduce preventable deaths and infectious diseases (malaria, hepatitis B/C, HIV, COVID-19 and others) with diagnostics, treatment and education programs, especially in high-prevalence areas. 8. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. I N N O VAT E. MAKING. ACCESS AND. AFFORDABILIT Y. CORE TO NEW. PRODUCT. I N N O VAT I O N. The FreeStyle Libre system is our This work translates into rapid access for groundbreaking continuous glucose people with diabetes, and a reduction in cost monitor.

8 From the beginning, we designed for local healthcare systems potentially affordability and broad access into this lessening the impact of one of the world's technology to reach more people with leading noncommunicable diseases. diabetes. We took steps at every stage to We took the same approach when we make it affordable and available to the created BinaxNOW , Abbott's new $5 rapid millions of people with diabetes starting COVID-19 test. We paired the test with our with our R&D, supply chain and high-speed mobile NAVICA app, allowing people who automated manufacturing, and then creating test negative to display their result on their a consistent global price and working with mobile device. This life-changing innovation governments to get it reimbursed. The result: can be mass produced at a rate of tens of Compared to other continuous glucose millions per month, attacking the pandemic monitors, FreeStyle Libre costs 70% on critical fronts when and where we need it most.

9 Our FreeStyle Libre sensor was designed to be discreet, painless to apply, easy to wear, water resistant, and smartphone compatible. i Based on a comparison of list prices of the FreeStyle Libre 14 day system versus competitors' CGM systems. FreeStyle Libre 2. system will be list priced the same rate as FreeStyle Libre 14 day system. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any. 9. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. TRANSFORM. TRANSFORMING. CARE FOR. CHRONIC DISEASE, M A L N U T R I T I O N, AND INFECTIOUS. DISEASES. We know firsthand that for every breakthrough from our team, there's another, even greater breakthrough, waiting to be discovered. For instance, take our Amplatzer Piccolo.

10 Occluder device. Originally developed for adults, our scientists and engineers worked to adapt this breakthrough technology to treat premature infants. Now, at no bigger than the size of a pea, this device closes holes in hearts of newborns, opening lifetimes of possibilities for the most vulnerable among us. By extending the reach of our own groundbreaking technologies, we will continue to create even more possibilities for millions more people around the world. Irie was born with the odds stacked against her. Piccolo changed that, sealing the opening in her tiny heart. Today she is a thriving toddler on the move who enjoys playing with her twin brother. 10. I N T R OD U C TI ON / INNOVATION / F O UNDATIO N / C REATIO N & MAN AG EMENT T H E AB B OT T 2 03 0 S U S TA INA B IL IT Y P L A N. PA R T N E R. A D VA N C I N G. H E A LT H E Q U I T Y.


Related search queries